Trading Experts Call It “The Perfect Tesla Trade”

Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.

CARA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $226,869.62

Cara Therapeutics Insider Trading History Chart

Cara Therapeutics Share Price & Price History

^$1.06

▲ +0.09 (9.28%)

As of 12/1/2023 01:00 AM ET

Days: 30 | 90 | 365

New CBOE “special perk” helps traders target income every weekend

From DTI Trader | Ad

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

Check out this training for the full story!

Cara Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/2/2023	Christopher Posner	CEO	Sell	3,796	$1.22	$4,631.12	164,411
8/3/2023	Christopher Posner	CEO	Sell	4,307	$3.07	$13,222.49	168,207
6/23/2023	Frederique Ph.D. Menzaghi	SVP	Sell	2,993	$3.51	$10,505.43	153,747
6/23/2023	Scott Terrillion	Insider	Sell	2,483	$3.51	$8,715.33	88,563
5/5/2023	Christopher Posner	CEO	Sell	3,869	$4.40	$17,023.60	172,514
4/4/2023	Frederique Ph.D. Menzaghi	SVP	Sell	2,733	$4.91	$13,419.03	156,740
4/4/2023	Scott Terrillion	Insider	Sell	2,481	$4.91	$12,181.71	91,046
2/2/2023	Christopher Posner	CEO	Sell	4,191	$11.80	$49,453.80	182,370
1/17/2023	Joana Goncalves	Insider	Sell	2,265	$10.81	$24,484.65	67,371
12/21/2022	Frederique Ph.D. Menzaghi	SVP	Sell	3,506	$11.27	$39,512.62	166,275
12/21/2022	Joana Goncalves	Insider	Sell	2,992	$11.27	$33,719.84	71,901
11/16/2022	Christopher Posner	CEO	Sell	14,470	$11.13	$161,051.10	186,561
9/14/2022	Martin Vogelbaum	Director	Sell	10,800	$10.28	$111,024.00	44,988
7/15/2022	Jeffrey L. Ives	Director	Sell	3,600	$9.05	$32,580.00	15,476
4/4/2022	Christopher Posner	CEO	Sell	2,006	$12.67	$25,416.02	201,031
4/1/2022	Frederique Ph.D. Menzaghi	SVP	Sell	1,784	$11.91	$21,247.44	169,781
4/1/2022	Scott Terrillion	Insider	Sell	1,642	$11.91	$19,556.22	74,893
3/3/2022	Scott Terrillion	Insider	Sell	1,787	$11.38	$20,336.06
3/3/2022	Thomas Charles Reilly	CFO	Sell	2,044	$11.38	$23,260.72
2/25/2022	Scott Terrillion	Insider	Sell	1,972	$10.29	$20,291.88
11/12/2021	Jeffrey L. Ives	Director	Sell	8,180	$16.04	$131,207.20
11/1/2021	Joana Goncalves	Insider	Sell	1,000	$17.15	$17,150.00
10/27/2021	Joana Goncalves	Insider	Sell	1,000	$15.00	$15,000.00
9/7/2021	Derek T. Chalmers	CEO	Sell	20,000	$15.47	$309,400.00	991,405
8/30/2021	Derek T Chalmers	CEO	Sell	8,440	$14.20	$119,848.00	1,011,405
8/30/2021	Frederique Ph.D. Menzaghi	SVP	Sell	3,847	$14.20	$54,627.40	141,072
8/30/2021	Scott Terrillion	Insider	Sell	1,759	$14.20	$24,977.80	47,900
8/30/2021	Thomas Charles Reilly	CFO	Sell	1,982	$14.20	$28,144.40
6/7/2021	Martin Vogelbaum	Director	Sell	8,640	$13.05	$112,752.00	28,800
4/21/2021	Joana Goncalves	Insider	Sell	3,000	$27.63	$82,890.00	43,610
3/22/2021	Joana Goncalves	Insider	Sell	3,000	$19.65	$58,950.00	30,610
3/5/2021	Derek T Chalmers	CEO	Sell	3,103	$17.98	$55,791.94	953,614
3/5/2021	Frederique Ph.D. Menzaghi	SVP	Sell	3,358	$17.98	$60,376.84	122,677
3/5/2021	Scott Terrillion	Insider	Sell	3,090	$17.98	$55,558.20	54,432
2/25/2021	Derek T Chalmers	CEO	Sell	11,729	$19.33	$226,721.57	955,343
2/25/2021	Frederique Ph.D. Menzaghi	SVP	Sell	5,003	$19.33	$96,707.99	117,680
2/25/2021	Scott Terrillion	Insider	Sell	4,004	$19.33	$77,397.32	48,436
1/21/2021	Joana Goncalves	Insider	Sell	2,000	$20.12	$40,240.00	28,075
12/30/2020	Derek T Chalmers	CEO	Sell	6,078	$15.30	$92,993.40	936,593
12/30/2020	Frederique Ph.D. Menzaghi	SVP	Sell	2,812	$15.30	$43,023.60	109,680
12/30/2020	Scott Terrillion	Insider	Sell	1,946	$15.30	$29,773.80	42,436
12/28/2020	Derek T Chalmers	CEO	Sell	5,000	$16.00	$80,000.00	947,671
12/21/2020	Joana Goncalves	Insider	Sell	2,000	$15.00	$30,000.00	27,373
12/16/2020	Derek T Chalmers	CEO	Sell	5,000	$14.95	$74,750.00	928,921
12/10/2020	Derek T Chalmers	CEO	Sell	7,500	$15.29	$114,675.00	933,921

New CBOE “special perk” helps traders target income every weekend

From DTI Trader | Ad

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

Check out this training for the full story!

SEC Filings (Institutional Ownership Changes) for Cara Therapeutics (NASDAQ:CARA)

68.04% of Cara Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Cara Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/1/2023	B. Riley Wealth Advisors Inc.	55,648	$93K	0.0%	-64.1%	0.102%
11/17/2023	Jacobs Levy Equity Management Inc.	1,444,088	$2.43M	0.0%	+41.2%	2.670%
11/16/2023	Tudor Investment Corp Et Al	93,116	$0.16M	0.0%	-51.2%	0.172%
11/16/2023	Penserra Capital Management LLC	81,542	$0.14M	0.0%	-49.5%	0.151%
11/15/2023	AQR Capital Management LLC	646,888	$1.09M	0.0%	N/A	1.196%
11/13/2023	Algert Global LLC	58,750	$99K	0.0%	N/A	0.109%
11/13/2023	Stifel Financial Corp	196,420	$0.33M	0.0%	+9.6%	0.363%
11/13/2023	Clearbridge Investments LLC	971,610	$1.63M	0.0%	-2.7%	1.797%
11/13/2023	Acadian Asset Management LLC	228,675	$0.38M	0.0%	N/A	0.423%
11/13/2023	FMR LLC	163,169	$0.27M	0.0%	+7.1%	0.302%
11/9/2023	Citigroup Inc.	44,821	$75K	0.0%	-24.0%	0.083%
11/9/2023	UBS Group AG	24,983	$42K	0.0%	-30.9%	0.046%
11/8/2023	Charles Schwab Investment Management Inc.	578,808	$0.97M	0.0%	+76.8%	1.070%
11/6/2023	Assenagon Asset Management S.A.	65,608	$0.11M	0.0%	N/A	0.121%
10/25/2023	Mackenzie Financial Corp	31,349	$51K	0.0%	N/A	0.058%
10/24/2023	Bank of New York Mellon Corp	165,252	$0.28M	0.0%	-12.6%	0.306%
10/24/2023	Pinnacle Associates Ltd.	649,253	$1.09M	0.0%	-3.4%	1.201%
10/18/2023	IQ EQ FUND MANAGEMENT IRELAND Ltd	848,845	$1.43M	0.3%	+904.2%	1.570%
10/13/2023	SG Americas Securities LLC	67,954	$0.11M	0.0%	+36.1%	0.126%
9/21/2023	Barclays PLC	9,346	$26K	0.0%	-67.1%	0.017%
9/7/2023	Jag Capital Management LLC	11,235	$32K	0.0%	N/A	0.021%
8/21/2023	California State Teachers Retirement System	15,558	$44K	0.0%	-72.6%	0.029%
8/15/2023	Alliancebernstein L.P.	93,220	$0.26M	0.0%	+96.7%	0.172%
8/15/2023	Wells Fargo & Company MN	44,717	$0.13M	0.0%	+12.1%	0.083%
8/15/2023	Public Employees Retirement System of Ohio	87,603	$0.25M	0.0%	N/A	0.162%
8/15/2023	Walleye Capital LLC	140,392	$0.40M	0.0%	N/A	0.260%
8/15/2023	Woodline Partners LP	631,351	$1.79M	0.0%	+1,385.2%	1.167%
8/15/2023	XTX Topco Ltd	52,025	$0.15M	0.0%	-51.7%	0.096%
8/15/2023	Goldman Sachs Group Inc.	285,851	$0.81M	0.0%	-5.9%	0.529%
8/15/2023	Point72 Middle East FZE	55,798	$0.16M	0.0%	+342.2%	0.103%
8/15/2023	Stifel Financial Corp	179,241	$0.51M	0.0%	+43.3%	0.331%
8/15/2023	Bain Capital Life Sciences Investors LLC	934,898	$2.65M	0.3%	-57.6%	1.729%
8/14/2023	PDT Partners LLC	85,088	$0.24M	0.0%	-16.6%	0.157%
8/14/2023	Ergoteles LLC	358,275	$1.01M	0.0%	N/A	0.662%
8/14/2023	Tudor Investment Corp Et Al	190,989	$0.54M	0.0%	+43.1%	0.353%
8/14/2023	Tower Research Capital LLC TRC	9,070	$26K	0.0%	+117.3%	0.017%
8/14/2023	Two Sigma Securities LLC	24,086	$68K	0.0%	+103.3%	0.045%
8/14/2023	Marshall Wace LLP	133,134	$0.38M	0.0%	N/A	0.246%
8/14/2023	Shay Capital LLC	12,500	$35K	0.0%	N/A	0.023%
8/14/2023	State Street Corp	919,458	$2.60M	0.0%	-51.7%	1.700%
8/14/2023	MML Investors Services LLC	57,866	$0.16M	0.0%	+33.6%	0.107%
8/14/2023	Graham Capital Management L.P.	19,168	$54K	0.0%	N/A	0.035%
8/11/2023	Jag Capital Management LLC	11,235	$32K	0.0%	N/A	0.021%
8/11/2023	Renaissance Technologies LLC	434,050	$1.23M	0.0%	+1,120.3%	0.803%
8/11/2023	Baird Financial Group Inc.	33,042	$94K	0.0%	N/A	0.061%
8/11/2023	BlackRock Inc.	3,701,968	$10.48M	0.0%	-51.3%	6.845%
8/11/2023	The Manufacturers Life Insurance Company	22,104	$63K	0.0%	+24.4%	0.041%
8/11/2023	Clearbridge Investments LLC	998,074	$2.83M	0.0%	+105.6%	1.846%
8/11/2023	Franklin Resources Inc.	26,301	$74K	0.0%	+75.6%	0.049%
8/11/2023	Geode Capital Management LLC	934,302	$2.64M	0.0%	+4.7%	1.728%
8/11/2023	JPMorgan Chase & Co.	41,087	$0.12M	0.0%	-46.1%	0.076%
8/11/2023	Northern Trust Corp	409,529	$1.16M	0.0%	-42.2%	0.757%
8/10/2023	Russell Investments Group Ltd.	34,039	$96K	0.0%	+2,524.4%	0.063%
8/10/2023	Charles Schwab Investment Management Inc.	327,420	$0.93M	0.0%	-2.5%	0.607%
8/10/2023	Citigroup Inc.	58,942	$0.17M	0.0%	-16.4%	0.109%
8/9/2023	Dimensional Fund Advisors LP	403,040	$1.14M	0.0%	-57.4%	0.747%
8/9/2023	BNP Paribas Arbitrage SNC	77,618	$0.22M	0.0%	+24.1%	0.144%
8/7/2023	Principal Financial Group Inc.	17,900	$51K	0.0%	-93.6%	0.033%
8/7/2023	Mirabella Financial Services LLP	14,257	$40K	0.0%	N/A	0.026%
8/3/2023	Barclays PLC	9,346	$26K	0.0%	-67.1%	0.017%
8/3/2023	Bank of New York Mellon Corp	189,175	$0.54M	0.0%	-53.3%	0.351%
7/27/2023	B. Riley Wealth Advisors Inc.	154,990	$0.44M	0.0%	+218.6%	0.287%
7/27/2023	Pinnacle Associates Ltd.	672,440	$1.90M	0.0%	-1.0%	1.246%
7/24/2023	Allspring Global Investments Holdings LLC	22,158	$63K	0.0%	+2,846.5%	0.041%
7/18/2023	Allspring Global Investments Holdings LLC	22,158	$63K	0.0%	+2,846.5%	0.041%
7/18/2023	Rothschild Investment Corp IL	15,100	$43K	0.0%	-46.8%	0.028%
7/10/2023	SG Americas Securities LLC	49,932	$0.14M	0.0%	-33.5%	0.093%
5/22/2023	Ameriprise Financial Inc.	244,181	$1.20M	0.0%	-3.4%	0.452%
5/18/2023	JPMorgan Chase & Co.	76,193	$0.38M	0.0%	+10.6%	0.141%
5/18/2023	New York State Common Retirement Fund	15,979	$78K	0.0%	-48.4%	0.030%
5/17/2023	B. Riley Wealth Advisors Inc.	48,648	$0.24M	0.0%	+5.4%	0.090%
5/16/2023	Jane Street Group LLC	13,628	$67K	0.0%	-77.2%	0.025%
5/16/2023	State Street Corp	1,902,942	$9.34M	0.0%	+7.1%	3.526%
5/16/2023	Squarepoint Ops LLC	195,818	$0.96M	0.0%	N/A	0.363%
5/16/2023	Geode Capital Management LLC	892,319	$4.38M	0.0%	+4.1%	1.653%
5/16/2023	Bain Capital Life Sciences Investors LLC	2,204,449	$10.82M	1.4%	-18.2%	4.084%
5/15/2023	Two Sigma Securities LLC	11,846	$58K	0.0%	N/A	0.022%
5/15/2023	Two Sigma Advisers LP	25,900	$0.13M	0.0%	N/A	0.048%
5/15/2023	Two Sigma Investments LP	163,736	$0.80M	0.0%	N/A	0.303%
5/15/2023	Deutsche Bank AG	32,920	$0.16M	0.0%	+37.1%	0.061%
5/15/2023	Ensign Peak Advisors Inc	47,620	$0.23M	0.0%	+13.3%	0.088%
5/15/2023	Kingdon Capital Management L.L.C.	1,233,000	$6.05M	1.1%	-7.5%	2.284%
5/15/2023	Farallon Capital Management LLC	1,995,370	$9.80M	0.1%	-3.8%	3.697%
5/15/2023	XTX Topco Ltd	107,610	$0.53M	0.1%	+669.4%	0.199%
5/12/2023	Renaissance Technologies LLC	35,568	$0.18M	0.0%	N/A	0.066%
5/12/2023	Stifel Financial Corp	125,099	$0.61M	0.0%	+50.8%	0.232%
5/12/2023	BlackRock Inc.	7,602,683	$37.33M	0.0%	-1.7%	14.086%
5/12/2023	BNP Paribas Arbitrage SNC	62,538	$0.31M	0.0%	+377.1%	0.116%
5/12/2023	Bank of America Corp DE	760,850	$3.74M	0.0%	+13.4%	1.410%
5/12/2023	HRT Financial LP	65,096	$0.32M	0.0%	N/A	0.121%
5/12/2023	Clearbridge Investments LLC	485,535	$2.38M	0.0%	+18.8%	0.900%
5/12/2023	UBS Group AG	38,801	$0.19M	0.0%	-35.8%	0.072%
5/12/2023	Public Sector Pension Investment Board	79,385	$0.39M	0.0%	-4.0%	0.147%
5/12/2023	Dimensional Fund Advisors LP	945,882	$4.64M	0.0%	-7.0%	1.752%
5/12/2023	Profund Advisors LLC	12,079	$59K	0.0%	N/A	0.022%
5/11/2023	ExodusPoint Capital Management LP	213,644	$1.05M	0.0%	-42.5%	0.396%
5/11/2023	Rhumbline Advisers	154,817	$0.76M	0.0%	+5.8%	0.287%
5/11/2023	Citigroup Inc.	70,535	$0.35M	0.0%	-4.8%	0.131%
5/10/2023	Credit Suisse AG	89,605	$0.44M	0.0%	+3.0%	0.166%
5/10/2023	Swiss National Bank	98,600	$0.48M	0.0%	-10.5%	0.183%

Data available starting January 2016

Cara Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. Its product candidate, including Oral KORSUVA (difelikefalin), which has completed Phase II clinical trial to treat pruritus atopic dermatitis and pruritus non-dialysis-dependent chronic kidney disease (NDD-CKD) associated pruritus; and in Phase II clinical trial to treat pruritus chronic liver disease (CLD) primary biliary cholangitis (PBC) and notalgia paresthetica. Cara Therapeutics, Inc. has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; Vifor Fresenius Medical Care Renal Pharma Ltd. and Winhealth Pharma for the co-development and commercialization of KORSUVA injection for the treatment of moderate-to-severe pruritus in adult patients undergoing hemodialysis in China; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. The company was incorporated in 2004 and is based in Stamford, Connecticut.

Today's Range

Now: $1.06

$0.93

$1.10

50 Day Range

MA: $1.29

$0.93

$1.79

52 Week Range

Now: $1.06

$0.90

$12.81

Volume

589,721 shs

Average Volume

816,071 shs

Market Capitalization

$57.75 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.94

Who are the company insiders with the largest holdings of Cara Therapeutics?: Cara Therapeutics' top insider investors include:
Christopher Posner (CEO)
Frederique PhD Menzaghi (SVP)
Scott Terrillion (Insider)
Joana Goncalves (Insider)
Martin Vogelbaum (Director)
Jeffrey L Ives (Director)
Thomas Charles Reilly (CFO)
Learn More about top insider investors at Cara Therapeutics.
Who are the major institutional investors of Cara Therapeutics?: Cara Therapeutics' top institutional investors include:
Jacobs Levy Equity Management Inc. — 2.67%
Clearbridge Investments LLC — 1.80%
IQ EQ FUND MANAGEMENT IRELAND Ltd — 1.57%
Pinnacle Associates Ltd. — 1.20%
AQR Capital Management LLC — 1.20%
Charles Schwab Investment Management Inc. — 1.07%
Learn More about top institutional investors of Cara Therapeutics stock.
Which institutional investors are selling Cara Therapeutics stock?: During the last quarter, CARA stock was sold by these institutional investors:
B. Riley Wealth Advisors Inc.
Tudor Investment Corp Et Al
Penserra Capital Management LLC
Clearbridge Investments LLC
Bank of New York Mellon Corp
Pinnacle Associates Ltd.
Citigroup Inc.
UBS Group AG
During the previous year, company insiders that have sold Cara Therapeutics company stock include:
Christopher Posner (CEO)
Frederique PhD Menzaghi (SVP)
Scott Terrillion (Insider)
Joana Goncalves (Insider)
Learn More investors selling Cara Therapeutics stock.
Which institutional investors are buying Cara Therapeutics stock?: During the previous quarter, CARA stock was purchased by institutional investors including:
IQ EQ FUND MANAGEMENT IRELAND Ltd
AQR Capital Management LLC
Jacobs Levy Equity Management Inc.
Charles Schwab Investment Management Inc.
Acadian Asset Management LLC
Assenagon Asset Management S.A.
Algert Global LLC
Mackenzie Financial Corp